Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up study

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Charalampos I MitsonisDemetrios C Vassilopoulos

Abstract

A growing body of evidence supports the association between Stressful Life Events (SLEs) and increased risk for relapse in Multiple Sclerosis (MS). In this open-label, randomized, controlled, one-year prospective study we investigated the effects of escitalopram on stress-related relapses in 48 women with relapsing-remitting MS. Patients were randomly assigned either to receive escitalopram 10mg/day (e-group, N=24) or to continue with treatment as usual, as a control group (c-group, N=24). SLEs were documented weekly in self-report diaries and were classified afterwards as short- or long-term depending on their psychological impact as this was subjectively felt by the patient. The cumulative risk for relapse was 2.9 times higher for controls than for escitalopram-treated patients (95% CI=1.7-5.1, p<0.001) and it was influenced only by long-term SLEs. In the e-group only 3 or more long-term SLEs were associated with a significant increase of the risk of a relapse during the following 4 weeks, and this risk was 4 times lower compared to the c-group. Our study shows preliminary evidence that escitalopram may constitute an effective and well-tolerated treatment option for the prevention of stress-related relapses in women with MS.

References

Dec 17, 1998·The Journal of Endocrinology·L ArboreliusC B Nemeroff
Jan 20, 2000·Behavioral Medicine·C E SchwartzM W Genderson
May 26, 2001·Hormones and Behavior·R AvitsurJ F Sheridan
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Steven C StoutCharles B Nemeroff
Apr 19, 2002·Brain : a Journal of Neurology·D BuljevacR Q Hintzen
Mar 18, 2003·Journal of Clinical Psychopharmacology·Thomas NickelFlorian Holsboer
Sep 23, 2003·BMJ : British Medical Journal·D BuljevacR Q Hintzen
Mar 24, 2005·The International Journal of Neuropsychopharmacology·Georg NikischAleksander A Mathé
May 19, 2005·Journal of the Neurological Sciences·Peter K Stys
Dec 1, 2005·The International Journal of Neuropsychopharmacology·Christer AllgulanderAnna K Trap Huusom
Apr 29, 2006·Neuroscience Letters·Jop P MostertJacques De Keyser
Dec 22, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nashat AbumariaGabriele Flügge
Jan 24, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Naomi A FinebergDan J Stein
Feb 7, 2007·Journal of Neuroendocrinology·C Schüle
May 3, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·J P MostertJ De Keyser
May 17, 2008·CNS Neuroscience & Therapeutics·Jop P MostertJacques De Keyser
Jul 11, 2008·Primary Care Companion to the Journal of Clinical Psychiatry·Chi-Un PaeAshwin A Patkar
Aug 30, 2008·Multiple Sclerosis : Clinical and Laboratory Research·C PotagasD Vassilopoulos
Sep 10, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Charalampos I MitsonisConstantin A Sfagos
Jan 1, 2009·The International Journal of Neuroscience·Charalampos I MitsonisKonstantinos Sfagos

❮ Previous
Next ❯

Citations

Jul 1, 2011·Indian Journal of Psychological Medicine·A HajhashemiM Etemadifar
Feb 25, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Swen HesseOsama Sabri
Mar 30, 2013·Autoimmunity Reviews·Anna KaragkouniTheoharis C Theoharides
Oct 25, 2013·International Review of Psychiatry·Nicole LichtblauHubertus Himmerich
Nov 1, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mark J Rapoport
Jul 28, 2013·Journal of Neuroimmunology·Aparna R ShenoyHarald H Hofstetter
May 24, 2016·Pharmacoepidemiology and Drug Safety·Tingting ZhangHelen Tremlett
Apr 5, 2019·The Journal of Neuropsychiatry and Clinical Neurosciences·Lisa B GrechRobert Hester
May 26, 2017·Multiple Sclerosis International·Sandipan BhattacharjeeTerri Warholak
Aug 28, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·L V KrivenkoM V Pashenkov
Jun 18, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·M V MelnikovA N Boyко
Mar 24, 2021·Multiple Sclerosis and Related Disorders·Mikhail MelnikovAlexey Boykо
Mar 30, 2021·Multiple Sclerosis and Related Disorders·C Danielle JonesBrian M Sandroff
May 18, 2021·Journal of Neuroimmunology·Anastasiya SviridovaMikhail Melnikov
Jun 8, 2021·Frontiers in Immunology·Eleni StamoulaGeorgios Papazisis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.